Switching androgen receptor antagonists to agonists by modifying C-ring substituents on piperidino[3,2-g]quinolinone.
L Zhi, C M Tegley, K B Marschke, T K Jones
文献索引:Bioorg. Med. Chem. Lett. 9(7) , 1009-12, (1999)
全文:HTML全文
摘要
New nonsteroidal human androgen receptor (hAR) agonists were developed from an hAR antagonist pharmacophore, 2(1H)-piperidino[3,2-g]quinolinone. (+/-)-trans-7,8-Diethyl-4-trifluoromethyl-2(H)-piperidino-[3,2-g]quinoli none was synthesized and demonstrated potent hAR agonist activity (EC50=3 nM) in the cell-based cotransfection assay and high binding affinity (Ki=16 nM) in the competitive receptor binding assay.
相关化合物
相关文献:
2012-12-01
[FASEB J. 26 , 4951-65, (2012)]
2011-05-01
[Bioorg. Med. Chem. Lett. 21 , 2736-9, (2011)]
2011-01-01
[PLoS ONE 6(1) , e16084, (2011)]
2010-01-01
[Microb. Cell Fact. 9 , 70, (2010)]